What is Kalvista Pharmaceuticals Inc (KALV) stock price today?

Kalvista Pharmaceuticals Inc (KALV) currently trades at $26.66 per share. The stock has a market capitalization of $1.42B and a P/E ratio of —x.

Is KALV stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Kalvista Pharmaceuticals Inc has a Smart Value Score of 28/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 4/9 and Altman Z-Score is -4.31.

What is Kalvista Pharmaceuticals Inc's revenue and earnings?

Kalvista Pharmaceuticals Inc has trailing twelve-month (TTM) revenue of $73.62M with profit margins of -223.20%. Earnings per share (EPS) is $-3.94.

Is Kalvista Pharmaceuticals Inc financially healthy?

Kalvista Pharmaceuticals Inc's Piotroski F-Score is 4/9 (moderate financial health). The Altman Z-Score of -4.31 places it in the distress.

KALV

Kalvista Pharmaceuticals Inc

NASDAQ: KALV · HEALTHCARE · BIOTECHNOLOGY

$26.66

+0.04% today

Updated 2026-05-04

Market cap

$1.42B

P/E ratio

—

P/S ratio

19.29x

EPS (TTM)

$-3.94

Dividend yield

—

52W range

$10 – $27

Volume

2.9M

Market cap

$1.42B

P/E ratio

—

P/S ratio

19.29x

EPS (TTM)

$-3.94

Dividend yield

—

52W range

$10 – $27

Volume

2.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

6.3

Growth

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

-4.3

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →197 stocks currently score above 75

Price targets

Analyst target

$31.60

+18.53%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy3 Buy4 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

+ Revenue growth 30.70% QoQ

Risks

- Altman Z -4.31 — distress zone

- Thin margins at -223.20%

- Negative free cash flow $-83.33M

- Debt/equity 8.80x — high leverage

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	2025	2026	TTM
Revenue	$0.00	$0.00	$0.00	$73.62M	$73.62M
Net income	$-92.91M	$-126.64M	$-183.44M	$-164.29M	$-164.29M
EPS	—	—	—	—	$-3.94
Free cash flow	$-76.46M	$-89.67M	$-153.34M	$-83.33M	$-83.33M
Profit margin	—	—	—	-223.16%	-223.20%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-26	VENROCK, HEALTHCARE CAPITAL PARTNERS III, L.P.	Sale	21,386	$17.76
2026-03-26	VENROCK, HEALTHCARE CAPITAL PARTNERS III, L.P.	Sale	15,417	$18.82
2026-03-26	VENROCK, HEALTHCARE CAPITAL PARTNERS III, L.P.	Sale	3,183	$19.12

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
KALV	$1.42B	28	6.3	2.0	5.0	5.0	—	Avoid
LLY	$862.01B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$546.90B	59	4.7	9.0	3.3	6.0	-40.34%	Buy
ABBV	$365.43B	63	4.0	8.0	4.0	5.0	-22.55%	Buy
UNH	$336.72B	54	5.3	5.5	7.3	4.8	+43.12%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+3.99%	Buy

Smart narrative

Kalvista Pharmaceuticals Inc trades at $26.66. Our Smart Value Score of 28/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -4.31, it sits in the distress. TTM revenue stands at $73.62M. with profit margins at -223.20%.

Frequently asked questions

What is Kalvista Pharmaceuticals Inc's stock price?

Kalvista Pharmaceuticals Inc (KALV) trades at $26.66.

Is Kalvista Pharmaceuticals Inc overvalued?

Smart Value Score 28/100 (Grade F, Strong Sell).

What is the price target of Kalvista Pharmaceuticals Inc (KALV)?

The analyst target price is $31.60, representing +18.5% upside from the current price of $26.66.

What is Kalvista Pharmaceuticals Inc's revenue?

TTM revenue is $73.62M.

Piotroski F-Score?

4/9 — moderate financial health.

Altman Z-Score?

-4.31 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.kalvista.com

Quick metrics

P/S ratio19.29x

ROE-190.20%

Beta-0.12

50D MA$18.80

200D MA$15.12

Shares out0.05B

Float0.03B

Short ratio—

Avg volume2.9M

Performance

1 week+35.86%

1 month+34.90%

3 months+70.85%

YTD+65.14%

1 year—

3 years—

5 years—

Compare

KALV vs LLY →KALV vs JNJ →KALV vs ABBV →Stock screener →